Photo: Assistant editor Kyle LaHucik for Endpoints News

#ASH22 Re­cap: Lead­ing hema­tol­ogy ex­perts talk top read­outs; Fire­side chat with No­vo Nordisk's Lu­dovic Helf­gott; More

The Amer­i­can So­ci­ety of Hema­tol­ogy wraps up every year with one of the biggest con­fer­ences in the bio­phar­ma in­dus­try. It’s a place where lots of new in­no­va­tions in hema­tol­ogy — from leukemia to mul­ti­ple myelo­ma to he­mo­phil­ia and more — are pre­sent­ed, dis­cussed, ques­tioned or even cel­e­brat­ed.

It’s al­so a place where net­work­ing is in its prime.

Af­ter two years of ei­ther vir­tu­al ap­pear­ances or re­duced at­ten­dance, it’s dif­fi­cult to un­der­state the at­mos­phere when peo­ple get to­geth­er for the con­fer­ence ex­pe­ri­ence in-per­son — a feel­ing ex­pressed by ASH pan­elist Noah Berkowitz from Bris­tol My­ers Squibb when he said this year’s con­fer­ence feels “like the ASH we all re­mem­ber.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.